Fludarabine Phosphate Suppliers & Bulk Manufacturers
Available Forms: Injection (IV), Oral Tablet
Available Strengths: Injection: 25 mg/ml; Tablet: 10 mg
Reference Brands: Fludara® (US & EU)
Category: Oncology Cancer Care
Fludarabine Phosphate is available in Injection (IV), Oral Tablet and strengths such as Injection: 25 mg/ml; Tablet: 10 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fludarabine Phosphate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Fludarabine Phosphate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Fludarabine Phosphate is a widely used oncology medication indicated for chronic lymphocytic leukemia (CLL) and certain non-Hodgkin’s lymphomas. It is available in the US and EU as a 25 mg/mL injection and 10 mg oral tablets. Marketed under the brand name Fludara® and as generics, Fludarabine Phosphate is a purine analog that interferes with DNA synthesis, promoting apoptosis in malignant cells. It is a critical chemotherapy option in hematologic cancer protocols and widely used in hospital oncology units and pharma B2B distribution. Its established efficacy and regulatory approval make it a trusted choice across global markets.
Frequently Asked Questions
Related Products
Atezolizumab
Strength:
1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View Details
Durvalumab
Strength:
120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View Details
Sunitinib
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers
